Market By Technology, Application, Component, End-user, And Geography | Forecast 2019-2027
As per one of Triton Market Research’s report, the 3D cell culture market in the Middle East and Africa is anticipated to surge in revenue, with a CAGR of 12.82% in the forecast years 2019 to 2027.
The countries included in the report on the Middle East and African 3D cell culture market are:
• Turkey
• Saudi Arabia
• South Africa
• The UAE
• Rest of MEA
The rate of incidence of cancer in Turkey is relatively higher than the world average. Besides, cancer is highly prevalent in countries in the Rest of the Middle East and Africa region, like Nigeria, Egypt, Uganda, Gambia, and Zimbabwe. As per the WHO data, 41,000 cancer deaths took place in Nigeria in 2018, out of approx. 166,000 cases that were recorded. In 2012, 108,600 people were diagnosed with cancer in Egypt. The alarming rates of cancer in these countries show an enhanced need for cancer-related research, which involves 3D cell culturing. Further research would lead to the development of a new drug against cancer, which is likely to fuel the market growth of 3D cell culture.
Report scope can be customized per your requirements. Request For Customization
Moreover, the use of regenerative medicine has also gained momentum in Nigeria. Adult stem cells and platelet-rich plasma (PRP) are being used to treat several health conditions, Such as chronic kidney disease, hypertension, joint pain, diabetes mellitus, and some neurological disorders in the country. The Nigerian government has been making efforts to make regenerative medicine more affordable for its citizens, by providing more grants to healthcare institutions. Thus, support from the government is another factor which is boosting Nigeria’s 3D cell culture market.
Merck KGaA is engaged in the development, manufacture, and marketing of pharmaceutical & biological prescription drugs for the treatment of cancer, growth disorders, infertility, multiple sclerosis, and certain metabolic and cardiovascular diseases. The group offers equipment, tools, and chemicals for academic laboratories, biopharmaceutical manufacturers, biotechnology companies, and the industrial sector.
Merck has strong research and development (R&D) capabilities. Its research activities majorly focus on the areas of immuno-oncology, neurology, oncology, general diseases, and immunology. The company reported revenues of EUR 3,746 million for the first quarter that ended in March 2019, with a decrease of 3.6% over the previous quarter. The company has its presence across Europe, the Middle East and Africa, the Asia-Pacific, Latin America, and North America.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. MIDDLE
EAST AND AFRICA 3D CELL CULTURE MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. PORTER’S
FIVE FORCES MODEL
2.2.1. THREAT
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTE
2.2.3. BARGAINING
POWER OF BUYERS
2.2.4. BARGAINING
POWER OF SUPPLIERS
2.2.5. THREAT
OF COMPETITIVE RIVALRY
2.3. ECONOMIC
TECHNOLOGICAL, AND POLITICAL & LEGAL OUTLOOK
2.4. REGULATORY
MARKET
2.5. KEY
INSIGHT
2.6. MARKET
ATTRACTIVENESS INDEX
2.7. MARKET
DRIVERS
2.7.1. GROWING
CANCER PREVALENCE
2.7.2. HIGH
DEMAND FOR ORGAN TRANSPLANTATION
2.7.3. PROMISING
DEVELOPMENTS USING REGENERATIVE MEDICINE
2.8. MARKET
RESTRAINTS
2.8.1. LACK
OF SKILLED PROFESSIONALS
2.8.2. INCOMPATIBILITIES
OF THE PREFERRED ANALYTICAL TECHNOLOGIES WITH 3D CELL CULTURE
2.9. MARKET
OPPORTUNITIES
2.9.1. INCREASING
USAGE OF 3D CELL CULTURE IN ORGAN TRANSPLANTATION AND DRUG SCREENING
2.9.2. TECHNOLOGICAL
ADVANCEMENT
2.10.
MARKET CHALLENGES
2.10.1.
LACK OF AVAILABILITY OF DATA
FOR RESEARCH ON 3D CELL CULTURE
2.10.2.
CHALLENGES ASSOCIATED WITH 3D
CELL CULTURE IN PERFORMING EXPERIMENTS
3. 3D
CELL CULTURE MARKET OUTLOOK – BY TECHNOLOGY
3.1. SCAFFOLD-BASED
3.1.1. HYDROGELS
3.1.2. POLYMERIC
SCAFFOLDS
3.1.3. MICROPATTERNED
SURFACE MICROPLATES
3.2. SCAFFOLD-FREE
3.2.1. HANGING
DROP MICROPLATES
3.2.2. SPHEROID
MICROPLATES CONTAINING ULTRA-LOW ATTACHMENT (ULA) COATING
3.2.3. MICROFLUIDIC
3D CELL CULTURE
3.2.4. MAGNETIC
LEVITATIONS & 3D BIOPRINTING
3.3. 3D
BIOREACTORS
4. 3D
CELL CULTURE MARKET OUTLOOK – BY APPLICATION
4.1. CANCER
4.2. TISSUE
ENGINEERING & IMMUNOHISTOCHEMISTRY
4.3. DRUG
DEVELOPMENT
4.4. STEM
CELL RESEARCH
4.5. OTHER
APPLICATIONS
5. 3D
CELL CULTURE MARKET OUTLOOK – BY COMPONENT
5.1. MEDIA
5.2. REAGENTS
AND CONSUMABLES
6. 3D
CELL CULTURE MARKET OUTLOOK – BY END-USER
6.1. BIOTECHNOLOGY
AND PHARMACEUTICAL ORGANIZATIONS
6.2. RESEARCH
LABORATORIES AND INSTITUTES
6.3. HOSPITALS
AND DIAGNOSTIC CENTERS
6.4. OTHER
END-USERS
7. 3D
CELL CULTURE MARKET – REGIONAL OUTLOOK
7.1. MIDDLE
EAST AND AFRICA
7.1.1. COUNTRY
ANALYSIS
7.1.1.1. SAUDI
ARABIA
7.1.1.2. TURKEY
7.1.1.3. UNITED
ARAB EMIRATES
7.1.1.4. SOUTH
AFRICA
7.1.1.5. REST
OF MIDDLE EAST & AFRICA
8. COMPANY
PROFILES
8.1. BECTON
DICKINSON AND COMPANY
8.2. TECAN
GROUP LTD.
8.3. PROMOCELL
GMBH
8.4. CORNING
INC.
8.5. NANO3D
BIOSCIENCES, INC.
8.6. 3D
BIOTEK, LLC
8.7. MERCK
KGAA
8.8. EMULATE
8.9. THERMO
FISHER SCIENTIFIC, INC.
8.10.
GE HEALTHCARE
8.11.
INSPHERO
8.12.
LONZA GROUP AG
8.13.
VWR CORPORATION
8.14.
SYNTHECON, INCORPORATED
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.1.1. OBJECTIVES
OF STUDY
9.1.2. SCOPE
OF STUDY
9.2. SOURCES
OF DATA
9.2.1. PRIMARY
DATA SOURCES
9.2.2. SECONDARY
DATA SOURCES
9.3. RESEARCH
METHODOLOGY
9.3.1. EVALUATION
OF PROPOSED MARKET
9.3.2. IDENTIFICATION
OF DATA SOURCES
9.3.3. ASSESSMENT
OF MARKET DETERMINANTS
9.3.4. DATA
COLLECTION
9.3.5. DATA
VALIDATION & ANALYSIS
TABLE
1 MIDDLE EAST AND AFRICA 3D CELL
CULTURE MARKET 2019-2027 ($ MILLION)
TABLE
2 MIDDLE EAST AND AFRICA 3D CELL
CULTURE MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE
3 MIDDLE EAST AND AFRICA
SCAFFOLD-BASED MARKET BY TYPE 2019-2027 ($ MILLION)
TABLE
4 MIDDLE EAST AND AFRICA
SCAFFOLD-FREE MARKET BY TYPE 2019-2027 ($ MILLION)
TABLE
5 MIDDLE EAST AND AFRICA 3D CELL
CULTURE MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE
6 MIDDLE EAST AND AFRICA 3D CELL
CULTURE MARKET BY COMPONENT 2019-2027 ($ MILLION)
TABLE
7 USAGE OF MEDIA IN DIFFERENT
STAGES OF ORGANOIDS FORMATION
TABLE
8 MIDDLE EAST AND AFRICA 3D CELL
CULTURE MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE
9 MIDDLE EAST AND AFRICA 3D CELL
CULTURE MARKET BY COUNTRY 2019-2027 ($ MILLION)
FIGURE
1 MIDDLE EAST AND AFRICA 3D CELL
CULTURE MARKET 2019-2027 ($ MILLION)
FIGURE
2 MIDDLE EAST AND AFRICA 3D CELL
CULTURE MARKET BY SCAFFOLD-BASED 2019-2027 ($ MILLION)
FIGURE
3 MIDDLE EAST AND AFRICA 3D CELL
CULTURE MARKET BY HYDROGELS 2019-2027 ($ MILLION)
FIGURE
4 MIDDLE EAST AND AFRICA 3D CELL
CULTURE MARKET BY POLYMERIC SCAFFOLDS 2019-2027 ($ MILLION)
FIGURE
5 MIDDLE EAST AND AFRICA 3D CELL
CULTURE MARKET BY MICROPATTERNED SURFACE MICROPLATES 2019-2027 ($ MILLION)
FIGURE
6 MIDDLE EAST AND AFRICA 3D CELL
CULTURE MARKET BY SCAFFOLD-FREE 2019-2027 ($ MILLION)
FIGURE
7 MIDDLE EAST AND AFRICA 3D CELL
CULTURE MARKET BY HANGING DROP MICROPLATES 2019-2027 ($ MILLION)
FIGURE
8 MIDDLE EAST AND AFRICA 3D CELL
CULTURE MARKET BY SPHEROID MICROPLATES CONTAINING ULTRA-LOW ATTACHMENT (ULA)
COATING 2019-2027 ($ MILLION)
FIGURE
9 MIDDLE EAST AND AFRICA 3D CELL
CULTURE MARKET BY MICROFLUIDIC 3D CELL CULTURE 2019-2027 ($ MILLION)
FIGURE
10 MIDDLE EAST AND AFRICA 3D CELL
CULTURE MARKET BY MAGNETIC LEVITATIONS & 3D BIOPRINTING 2019-2027 ($
MILLION)
FIGURE
11 MIDDLE EAST AND AFRICA 3D CELL
CULTURE MARKET BY 3D BIOREACTORS 2019-2027 ($ MILLION)
FIGURE
12 MIDDLE EAST AND AFRICA 3D CELL
CULTURE MARKET BY CANCER 2019-2027 ($ MILLION)
FIGURE
13 MIDDLE EAST AND AFRICA 3D CELL
CULTURE MARKET BY TISSUE ENGINEERING & IMMUNOHISTOCHEMISTRY 2019-2027 ($
MILLION)
FIGURE
14 MIDDLE EAST AND AFRICA 3D CELL
CULTURE MARKET BY DRUG DEVELOPMENT 2019-2027 ($ MILLION)
FIGURE
15 MIDDLE EAST AND AFRICA 3D CELL
CULTURE MARKET BY STEM CELL RESEARCH 2019-2027 ($ MILLION)
FIGURE
16 MIDDLE EAST AND AFRICA 3D CELL
CULTURE MARKET BY OTHER APPLICATIONS 2019-2027 ($ MILLION)
FIGURE
17 MIDDLE EAST AND AFRICA 3D CELL
CULTURE MARKET BY MEDIA 2019-2027 ($ MILLION)
FIGURE
18 MIDDLE EAST AND AFRICA 3D CELL
CULTURE MARKET BY REAGENTS AND CONSUMABLES 2019-2027 ($ MILLION)
FIGURE
19 MIDDLE EAST AND AFRICA 3D CELL
CULTURE MARKET BY BIOTECHNOLOGY AND PHARMACEUTICAL ORGANIZATIONS 2019-2027 ($
MILLION)
FIGURE
20 MIDDLE EAST AND AFRICA 3D CELL
CULTURE MARKET BY RESEARCH LABORATORIES AND INSTITUTES 2019-2027 ($ MILLION)
FIGURE
21 MIDDLE EAST AND AFRICA 3D CELL
CULTURE MARKET BY HOSPITALS AND DIAGNOSTIC CENTERS 2019-2027 ($ MILLION)
FIGURE
22 MIDDLE EAST AND AFRICA 3D CELL
CULTURE MARKET BY OTHER END-USERS 2019-2027 ($ MILLION)
FIGURE
23 SAUDI ARABIA 3D CELL CULTURE MARKET
2019-2027 ($ MILLION)
FIGURE
24 TURKEY 3D CELL CULTURE MARKET
2019-2027 ($ MILLION)
FIGURE
25 UNITED ARAB EMIRATES 3D CELL CULTURE
MARKET 2019-2027 ($ MILLION)
FIGURE
26 SOUTH AFRICA EMIRATES 3D CELL CULTURE
MARKET 2019-2027 ($ MILLION)
FIGURE
27 REST OF MIDDLE EAST& AFRICA 3D
CELL CULTURE MARKET 2019-2027 ($ MILLION)